Bharat Biotech’s Covaxin gets approval for Phase 2, 3 trials for 2-18-year-olds
THD NewsDesk, New Delhi: Bharat Biotech's Covid-19 vaccine "Covaxin" has been approved for the phase II/III clinical trial on those aged ...
THD NewsDesk, New Delhi: Bharat Biotech's Covid-19 vaccine "Covaxin" has been approved for the phase II/III clinical trial on those aged ...
A daily dose of news, views, opinions, and actionable information from the global healthcare industry. Our newsletter is available for a limited audience. If you are interested to write or contribute to this portal then please get in touch.
© 2025 - The Healthcare Daily